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ABSTRACT 
Objective: The objective of this study is to determine the validity of analytical methods in OFX antibiotic study in human urine (in vitro) using an 
SPE-HPLC/UV. In this study, SPE was applied in preparing the analysis of ofloxacin using HPLC embedded UV detector.  
Methods: C-18 (octadecylsilane) cartridge (100 mg, particle size 10 µm) of SPE was employed in preparing a sample to determine further of 
analytes using HPLC with phosphate buffer 0.025 M (pH 2.5) and acetonitrile (85.5:14.5) as mobile phase and a flow rate of 1.2 m l/min. UV detector 
was adjusted at 295 nm with the internal standard ciprofloxacin. 
Results: The calibration curves for the ofloxacin were linear over concentrations ranging from 1.15 to 36.0 µg/ml with a correlation coefficient (r) from 
0.9998 to 0.9999. The coefficients of variation obtained from ofloxacin were less than 10 %. Ofloxacin on the area ratio of peak height and a segment of 
the chromatogram, LOD and LOQ of ofloxacin were 0.12 and 0.4 μg/ml, respectively. The recovery of ofloxacin from spiked human urine was 96.0 %.  
Conclusion: The validation methods that including parameters: selectivity, repeatability, linearity, detection limit, quantification limit, precision, accuracy, 
and suitability of the system. The methods used have validity according to the requirements that might be used to analyze ofloxacin in human urine. 
Keywords: Ofloxacin, Solid Phase Extraction, HPLC. 
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INTRODUCTION 
Sample preparation is an important part of the analysis of drug in a 
material biologic sample which able to determine the efficacy of 
analysis because it can establish reproducibility and recovery of the 
matrix interference [1-4]. The parent metabolite compound (such as 
protein, carbohydrate, and lipid) should be reduced because the 
existence of a drug may give misinterpreting results in analysis 
methods [5]. Therefore, it is needed the method that could 
accurately identify both the parent drug and metabolites. 
Application of SPE (Solid Phase Extraction) in sample preparation 
can reduce solvent volume and time [2, 6, 7]. In the previous 
research, application of SPE in the determination of lead compounds 
aromatherapy in blood plasma of mice after essential inhalation oil 
obtain good reliability (recovery 90 %) and reproducibility 
(variation coefficient less than 15 %). 
Oflaxocin (OFX) (9-fluoro-2,3-dihydro-3-methyl-10-(-methyl-1-
piperzinyl)-7-oxo-7H-pyrido-[1,2,3-de]1,4-bonzoxazine-6-carboxylic 
acid)as shown fig. 1 is which second generation quinolones are broad 
spectrum [8-10]. It has activity against both gram-positive and gram-









Fig. 1: Structure of ofloxacin 
The methods of determination of OFX in human plasma were 
published by many researchers [13-17] for bioavailability and 
bioequivalence study. Application of Solid Phase in preparation 
sample of OFX analysis in human urine has been reported [18-20].  
Here, the preliminary study was carried out prior to the clinical 
study, using human urine. The simple and validated method for 
measuring the concentration of the OFX in spiked human urine was 
required in a clinical test. 
The aim of this study is to develop a simple and reliable HPLC method 
for measurement of ofloxacin concentrations in spiked human urine 
with application SPE for preparation sample. The further 
recommendation will help in clinical study and routine analysis. 
MATERIALS AND METHODS 
Chemicals 
OFX and ciprofloxacin were purchased from Zhejiang Jinxin, China. 
All chemicals were used as received without further purification and 
all solvents were of reagent grade: sodium dihydrogen phosphate 
monohydrate (Merck), acetonitrile, and phosphoric acid (Merck), 
methanol pa (Merck), aqua bidest (IPHA), human urine (volunteer, 
man 20-24 age). 
Tools 
HPLC (Shimadzu LC-10 ATVP) embedded with UV-VIS detector SPD, 
auto-injector Shimadzu system controller SCL-A, the HPLC column 
(Phenomenex); length of 250 mm, 4.6 mm internal diameter, particle 
size 10 µm, UV-Vis spectrophotometer (Analytical Jena, specord 
200), pH meter (Oh meter), ultrasonic bath (Ney 1510), HLB 30 mg 
SPE cartridge 1 cc (Oasis), an analytical balance (Sartorius) 
sensitivity of 0.1 mg, filters vacuum with 0.4 to 0.45 µm pore filter, 
and an unusual glassware. 
Methods 
The mobile phase was a mixture of 0.025 M phosphate buffer pH 2.2 
and acetonitrile (85:15). The mixture was filtered using 0.45 p. m 
millipore with vacuum assistance and ultrasonic bath for 15-20 min. 
Standard solution preparation 
OFX 100 mg dissolved in 200 ml measuring flask with mobile phase 
to achieve the final concentration of 0.5 mg/ml, diluted with mobile 
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phase to obtain concentrations of 5 mg/ml. The in-scanning solution 
with a UV-spectrophotometer at a wavelength of 200-320 nm, so the 
obtained spectrum maximum wavelength (λ max) of absorption and 
OFX. The same procedure conducted on ciprofloxacin. 
Determination of molar extinction 
OFX standard solution with a concentration of 6.9, 13.5, and 18.0 pM 
measured at a wavelength of maximum absorbance OFX, and the 
calculated values molar extinction. 
Optimization of HPLC conditions 
OFX standard solution 0.1 mg/ml containing the internal standard 
ciprofloxacin 0.1 mg/ml was injected with 10 p. l (auto-injector) into the 
HPLC mobile phase composition of 85:15, 85,5:14,5, and 86: 14 v/v and 
flow rate was 1.2 and 1.3 ml/min. Viewed retention time and separation 
of the two peaks (OFX and ciprofloxacin) were produced. 
Extraction by solid phase extraction (SPE) 
The cartridge of SPE was conditioned by 1 ml of methanol and 1 ml 
aqua bidest with vacuum assistance. OFX was spiked into plasma 
with various concentration (0.10, 0.25, 1.00, 2.00, 3.00, 4.00, 5.00, 
and 6.00 µg/ml). Subsequently, 1 ml of plasma was put into a 
cartridge of SPE eluted by 1 ml acetonitrile 20% (in phosphate 
buffer) further injected into the HPLC. The efficiency of SPE 
extraction was calculated. 
Method validation analysis 
Selectivity was measured by looking at the chromatogram OFX and 
ciprofloxacin that obtained from HPLC separation, further calculated 
the value of the resolution. Repeatability was evaluated by generating 
a solution of OFX 0.25µg/ml in blood plasma and further extracted by 
using SPE. 10 µl of analyte was injected into the HPLC equipment in 
optimum condition; the experiment was repeated six times and then 
calculated the coefficient of variation. The linearity was determined by 
making the standard curve of five serial concentrations of OFX (0.10, 
0.25, 2.00, 4.00, and 6.00 µg/ml) and the internal standard 
ciprofloxacin 3 µg/ml in human urine, further extracted using SPE. 
HPLC system embedded with UV (294 nm) to be used as followed 
column C-18 (octadecyl silane), length of 250 mm, diameter in 4.6 
mm, and the particle size of 10 im, mobile phase 0.025 M phosphate 
buffer pH 2.5 and acetonitrile with ratio of 85.5: 14.5 v/v, and flow 
rate 1.2 ml/min. 
Precision, accuracy, and recovery 
Calibration curve equation with the best correlation coefficient was 
used to specify the sample. LOD and LOQ were determined 
statistically from the calibration curve equation using linear 
regression. Accuracy and precision were obtained by making the 
sample solution OFX 1, 3, and 5 lag/ml and the internal standard 
ciprofloxacin 3 lag/ml in blood plasma was extracted using SPE. 10 
µl of analyte injected into the HPLC equipment in optimum 
condition; the experiment was repeated three times and then 
calculated percent accuracy (recovery) and precision (coefficient of 
variation). System suitability test conducted on samples OFX 0.25 
lag/ml and the internal standard ciprofloxacin 3µg/ml in blood 
plasma, and then extracted using SPE. Ten microliters of analyte 
were injected into the HPLC equipment in optimum condition, done 
six times a repetition then calculated the coefficient of variation of 
retention time, area ratio, and peak height ratio chromatogram. 
RESULTS AND DISCUSSION 
The determination of maximum wavelength (λ max) 
The result of scanning using UV at the wavelength of 200-380 nm of 
OFX solutions in the mobile phase (phosphate buffer pH 2.5 and 
acetonitrile with a ratio of 85.5: 14.5) showed maximum absorption 
of OFX at λ max of 294 nm. This result was in line with a previous 
study [21]. Subsequently, the spectrum absorption of ciprofloxacin 
as a standard was observed. It showed a quite similar λ max to OFX 
(277 nm). However, the previous study obtained that the λ max of 
OFX is 275 nm [22] and 278 nm [23].  
On the other hand, the result of the combined spectra of both 
compounds showed the point of intersection at a wavelength of 
286.2 nm, as shown in fig. 1. 
 
 
Fig. 1: Spectrum of ciprofloxacin (blue line) was 277 nm dan OFX (green line) was 294 nm 
 
Ciprofloxacin was used as an internal standard due to it has identical 
chemical structure and properties OFX thus it could be eluted as 
OFX. The purpose of using internal standard is to reduce errors 
during the analysis process, particularly, for samples undergoing 
pre- treatment's, such as extraction, and filtration [24]. y applying 
the internal standard technique, it was expected to produce 
sensitive, relatively fast, and accurate method for the analysis of OFX 
in biological  the internal standard technique. 
The λ max of OFX was set as the wavelength used in the detection of the 
analysis result by HPLC, as OFX was the compound of target analysis, 
ciprofloxacin then provided large absorption at the λ max of OFX. 
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The determination result of molar extinction value of OFX  
The determination of molar extinction value has been conducted to 
obtain the sensitivity value of OFX. It could be calculated by 
comparing the absorptivity value or of molar OFX absorptivity 
towards the thickness of cuvette (usually 1 cm), with the OFX 
concentration measured[25]. The extinction value of molar OFX 
from three varied concentrations was 6.9; 13.5; and 18 μM in 0.1 M 
HCl in a row. It showed that the molar extinction value had an 
average value of 3.2 104M-1 cm-1. This molar extinction value was 
greater than 10.000 M-1 cm-1, indicating that OFX was possible to 
detect the ultraviolet detector on the HPLC system. The extinction 
value of OFX could be seen in table 1. The other study measured the 
extinction value of OFX in 0.1 M HCl at 293 nm and produced 3.5. 104 
M-1 cm-1 [26]. However, this result was determined with different 
diluted concentration. 
 
Table 1: The extinction molar (ε) value of OFX 
Extinction molar data OFX in mobile phase at 295 nm 













Jumlah    9.9.104 
X    3,3.104 
* Mobile phase = Buffer phosphat: acetonitril (85: 15) 
 
Optimization result of HPLC condition 
Optimization result of HPLC condition has been employed 
chromatography parameters, including the retention time, 
resolution or separation (Rs), efficiency (N) and column efficiency 
(HETP) from various compositions. The flow rate of the mobile 
phase was presented in table 2. The main priority in selecting the 
method was the resolution value result ≥ 1.5[27]. Based on the Rs 
value ≥ 1.5, it showed that the two peaks were completely separated. 
The second priority was the retention time, meaning that the faster 
retention time was better because the analysis time required will be 
faster. Efficiency (N) ≥ 2500 showed that the peaks produced were 
sharp. The theoretical chip value would increase by lowering the 
flow rate of the mobile phase or by increasing the length of the 
column, but the analysis time would remain longer.  
The mobile phase composed 0.025 M phosphate buffer pH 2.5 and 
acetonitrile (85: 15) with a flow rate of 1.2 ml/min, it obtained the 
retention time of OFX in 11.767 min. This condition was in a good state, 
but there was a disruption of urine that used to be separated in the early 
minutes of separation. Therefore, it was necessary to examine another 
mobile phase condition to slow the retention time of OFX. 
Furthermore, the observation continued to try a mobile phase 
composed of 0.025 M phosphate buffer pH 2.5 and acetonitrile (85.5: 
14.5) with the flow rate of 1.2 ml/min. The retention time of OFX 
obtained was 12.533 min while; at the flow rate of 1.3 ml/min, the 
retention time of OFX obtained was 11.375 min. The retention time 
of OFX obtained with the mobile phase composed of 0.025 M 
phosphate buffer pH 2.5 and acetonitrile (86: 14) with a flow rate of 
1.2 ml/min is 14,250 min, while at the flow rate of 1.3 ml/min, the 
retention time of OFX obtained is 12.750 min.  
The mobile phase composed of 0.025 M phosphate buffer pH 2.5 and 
acetonitrile (85.5: 14.5) was chosen, since it produces a good 
resolution, 1,77 (≥ 1.5). The flow rate of 1.2 ml/min was chosen to 
optimize the analysis condition because the other slower flow rate 
would take longer time. The previous study, the mobile phase used 
in OFX analysis was sodium lauryl sulfate (0.024% aqueous 
solution)-acetonitrile-glacial acetic acid (500:480:20) [28] or water-
acetonitrile-triethylamine (83:14:0.45, v/v, pH 2.30) [29]. 
The number of theoretical chips (N) in each condition was ≥ 2,500. It 
indicated that the peak produced was quite sharp [30]. In addition, 
the number of theoretical chips could be used to determine the 
quality and performance of the column. The theoretical chip value 
would rose by lowering the flow rate of the mobile phase or by 
increasing the length of the column, thereby taking the analysis time 
much longer.  
The result of condition optimization using solid phase 
extraction (SPE) 
The first step of extraction using SPE was conditioned with adding 1 
ml of methanol and 1 ml aqua bidest to clean impurities (exposure) 
in SPE cartridge during storage and also to wet the SPE cartridge 
[31]. Urine sample spiked by OFX was put in SPE cartridge as much 
as 1 ml (Sample Loading). The addition of sample has been carried 
out by drop wise while being energized by negative air pressure 
using a vacuum to speed up the extraction process and prevent 
clogged SPE cartridge. 
The washing process in SPE phase has been done by adding 1 ml of 
methanol 3% (in aqua bidest) to clean impurities (endogenous 
substances) in the urine and conserve the peaks of OFX and ciprofloxacin 
when analyzed by HPLC. Elution process has been conducted by adding 
1 ml of acetonitrile 20% (in 0.025 M phosphate buffer pH 2.5). It was 
expected that the OFX and ciprofloxacin remained in the SPE cartridge 
could be eluted or completely pushed out. The output analyte was 
accommodated in a container, to be analyzed by HPLC. 
Elution process was utilizing acetonitrile 20% in 0.025 M phosphate 
buffer pH 2.5 was sufficient to elute OFX and ciprofloxacin from SPE 
cartridges. It could be seen from the generated value of the 
extraction efficiency, which is ≥ 85% for two concentrations, 
respectively 1.8 and 36 μg/ml. Organic solvents with stronger 
elution could be used to obtain a better elution result, otherwise 
using the composition of acetonitrile that is greater than 20%. Due 
to the composition of the elution containing phosphate buffer pH 2.5 
and acetonitrile is in accordance with the composition of the mobile 
phase of the HPLC system used, the elution result could be directly 
injected into the HPLC system. 
 
Table 2: Recovery of extraction of OFX 1.8 and 36 µg/ml with internal standard of ciprofloxacin 10 μg/ml based on to area under curve of 
chromatogram (n = 3) 
Recovery of OFX (%) Recovery of ciprofloxacin (%) 
Replication OFX (μg/ml) Replication ciprofloxacin (μg/ml) 



















X  99.77 99.27 X  91.09 95.76 
CV 0.0217 0.0017 CV 0.0565 0.0369 
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To determine the recovery efficiency of the extraction result, the 
evaluation of extraction efficiency was conducted towards two 
samples with the concentrations of 1.8 and 36 µg/ml. After that, 
the injection result in the form of chromatogram area and peak 
chromatogram height of each sample in the mobile phase without 
the SPE between the SPE phases in the urine was compared. In 
table 2, it could be seen that SPE result of the low concentration is 
1.8 µg/ml based on the chromatogram area provides 99.77% of 
the extraction efficiency of OFX and 91.09% of ciprofloxacin while 
the high concentration of 36 μg/ml is 99.27% and 95.76% 
respectively. 
Extraction result using the SPE as a whole for μg/ml was very 
satisfying, because of the extraction efficiency is ≥ 85% and the 
value has met the extraction efficiency requirement>80%[32]. 
Chromatogram extraction recovery could be seen in fig. 2. 
 
 
Fig. 2: Chromatogram of recoveryextraction OFX 36 µg/ml, (purple) in moble phase and (blue) in urine 
 
Selectivity 
Selectivity test has been done by observing the resolution 
indicated at the peak of Rt = 9.867 min for OFX that was perfect 
apart from the top of ciprofloxacin peak Rt = 11.100 min, with a 
resolution value of 1.7 exceeding the recommended requirement 
for a good resolution value, which is ≥ 1.5. According to the 
resolution value, the HPLC method used had a good selectivity, and 
could be used to determine the OFX levels by using internal 
ciprofloxacin standard. 
Repeatability tests result 
Repeatability test was applied to the OFX sample with a 
concentration of 1.8 μg/ml, using ciprofloxacin of 10 μg/ml as an 
internal standard. The replication was performed 6 times, while the 
retention time, chromatogram area, and high peak chromatogram 
are observed afterward. The average retention time for OFX was 
10.07 min and CV value being<0.67. It indicated a good repeatability 
value, whereas the required value is<20% for biological fluid sample 
analysis [27]. The results were presented in table 3. 
 
Table 3: Repeatability analysis results of OFX 1,8 μg/ml with Internal Standard of Ciprofloxacin 10 μg/ml in Urine (n = 6) based on retention time 
OFX  
(μg/ml) 
Retention time (min) 

























X  10.07 11.34 0.8883063 
CV 0.66267 0.69581 0.09769 
 
Table 4: Repeatability analysis results of OFX 1,8 μg/ml with internal standard of ciprofloxacin 10 μg/ml based on area under curve 
OFX  
(μg/ml) 
Area under curve 

























X  80917.33 148539.5 0.54454673 
CV 0.10998 0.01598 0.10466 
The repeatability results were good for the CV was<0.11 (table 4), while the required value is<0.2 for the analysis of biological fluid sample[33]. 
Likewise, the result of repeatability based on chromatogram peak height ratio indicated a good value with a coefficient of variation (CV)<0.05 (table 4). 
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In particular literature, strict criteria were obtained if the method 
provides relative standard deviation, or 2% or less of CV. However, 
this value was very flexible depending on the concentration of the 
analyte analyzed, the number of samples, and laboratory condition. 
The variation coefficient would increase as the analyte level 
analyzed decrease [27, 33, 34]. The data proved that the method 
used has a good repeatability, with CV value <20% for the analysis of 
biological fluid sample[27, 34]. 
Linearity result 
Linearity test was conducted to observe the capability of analytical 
method in giving a good response to various analyte concentrations 
on a calibration curve in order to produce a straight line. The 
parameter concerning linear relationship was expressed by the 
correlation coefficient and a valid analytical method which has a 
correlation coefficient more than 0.998[33]. 
 
 
Fig. 3: Calibration curve of OFX with ranged concentration (1,8-
36 μg/ml) that obtained internal standard of ciprofloxacin 10 
μg/ml based on ratio of Area Under Curve of chromatogram 
 
OFX extraction result of ciprofloxacin in the urine was ranged from 
1.8-36 µg/ml obtaining a linear calibration curve with the line 
equation y = 0,2172x+0.2656 and the correlation coefficient (R) = 
0.9982, containing ciprofloxacin internal standard 10 μg/ml based 
on the ratio of chromatogram area (fig. 3). 
Limit of detection (LOD) and limit of quantitation (LOQ)  
The absolute limit of detection (LOD) was determined when the 
concentration of the analyte analyzed was relatively small as in 
biological matrix [30, 35]. The result of the limit of detection (LOD) 
test was calculated based on the calibration curve from an equation 
with the best correlation coefficient (r). The LOD value was 
depending on the calibration curve of OFX towards the ratio of the 
chromatogram area[29]. The LOD value of the area ratio was 0.12 
µg/ml. 
The absolute limit of quantitation (LOQ) is determined when the 
concentration of the analyte analyzed relatively small as in biological 
matrix [30, 35]. The result of the limit of quantitation (LOQ) test was 
calculated based on the calibration curve of OFX in accordance with an 
equation that had the best correlation coefficient (r). LOQ value was 
determined from the calibration curve of OFX towards the ratio of 
chromatogram area. LOQ value of the area ratio was 0.4 µg/ml.  
Precision and accuracy  
According to the calculation of the sample levels based on 
chromatogram area, it provided precision values expressed as CV 
from concentrations of 1.8 CV; 9 and 36 µg/ml, 0.16; 0,025; and 
0.038, respectively. The value was fair as required (<20%) for the 
analysis of biological fluid sample [30]. While the accuracy values in 
% sample recovery with concentrations of 1.8; 9 and 36 µg/ml were 
80.09%; 109.89% and 90.01%, respectively. The values obtained 
were fairly good as required as 80-110% [33]. 
 
Fig. 4: Chromatogram in system suitability of OFX 1.8 μg/ml with internal standard ciprofloxacin 10 μg/ml in human urine 
 
Table 5: System suitability analysis of OFX in concentration 1.8 μg/ml with internal standard of ciprofloxacin 10 μg/ml in human urine (n = 6) 
Parameters OFXIn 1.8 μg/ml 
Variation coefficient (CV) 
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Table 5 showed that the Consistent Variation (CV) from the 
retention time, the ratio of the chromatogram area, and the 
chromatogram peak height ratio ≤ 10% for the analysis of the 
biological fluid sample. It indicated that the method used had good 
system suitability. 
The suitability of the system was also used to determine the 
asymmetry factor and tailing factor of the peak. The asymmetry and 
tailing factors were used to determine the column condition and the 
experimental condition. The OFX peak of asymmetry with a 
concentration of 1.8 μg/ml was equal to 0.91-1.04 while the 
ciprofloxacin was equal to 1.02-1.11. The asymmetry value has met 
the criteria of the<2[27]. The tailing factor value for the peak of OFX 
with a concentration of 1.8 μg/ml was equal to 1.02 to 1.16 and for 
ciprofloxacin was equal to 1.02 to 1.05. The tailing factors obtained 
have met the requirements value, which was < 2 (the chromatogram 
could be seen in fig. 4). 
CONCLUSION 
OFX in human urine could be extracted by using SPE Oasis HLB 1 
thus further analysis by HPLC embedded UV detector with recovery 
more than 96 %. The validation methods that including parameters: 
selectivity, repeatability, linearity, detection limit, quantification 
limit, precision, accuracy, and suitability of the system, the methods 
used were valid according to the requirements that might be used to 
analyze OFX in human urine. 
ABBREVIATION 
HPLC/UV: High-Performance Liquid Chromatography-Ultra Violet, 
SPE: Solid Phase Extraction, LOD: Limit of Detection, LOQ: Limit of 
Quantification, OFX: ofloxacin. 
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